Initial outcomes of mitomycin intravascular chemoembolization (MICE) for corneal neovascularization.

Preliminary findings suggest that MICE may be an additional modality for treating progressive corneal NV with lipid keratopathy. Larger comparative studies with longer follow-up are warranted.